Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1969 1
1970 1
1974 1
1975 1
1977 1
1983 1
1990 1
1991 3
1992 2
1993 1
1994 1
1995 2
1996 1
1997 3
1998 7
1999 14
2000 2
2001 2
2002 2
2003 5
2004 2
2005 4
2006 2
2007 3
2009 3
2010 1
2011 3
2012 2
2013 6
2014 7
2015 9
2016 11
2017 9
2018 6
2019 14
2020 15
2021 11
2022 9
2023 8
2024 13
2025 14
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Methotrexate, Doxorubicin, and Cisplatin Versus Methotrexate, Doxorubicin, and Cisplatin + Ifosfamide in Poor Responders to Preoperative Chemotherapy for Newly Diagnosed High-Grade Osteosarcoma (JCOG0905): A Multicenter, Open-Label, Randomized Trial.
Hiraga H, Machida R, Kawai A, Kunisada T, Yonemoto T, Endo M, Nishida Y, Nagano A, Ae K, Yoshida S, Asanuma K, Toguchida J, Furuta T, Nakayama R, Akisue T, Hiruma T, Morii T, Nishimura H, Hiraoka K, Takeyama M, Emori M, Tsukushi S, Hatano H, Kawashima H, Isu K, Tanaka K, Kataoka T, Fukuda H, Iwamoto Y, Ozaki T. Hiraga H, et al. Among authors: yonemoto t. J Clin Oncol. 2025 Jun;43(16):1886-1897. doi: 10.1200/JCO-24-01281. Epub 2025 Mar 26. J Clin Oncol. 2025. PMID: 40138604 Free PMC article. Clinical Trial.
Prognostic factors of metastatic myxoid liposarcoma.
Shinoda Y, Kobayashi E, Kobayashi H, Mori T, Asano N, Nakayama R, Morioka H, Iwata S, Yonemoto T, Ishii T, Hiruma T, Kawai A, Kawano H. Shinoda Y, et al. Among authors: yonemoto t. BMC Cancer. 2020 Sep 14;20(1):883. doi: 10.1186/s12885-020-07384-1. BMC Cancer. 2020. PMID: 32928160 Free PMC article.
Fluorescence in situ hybridization-negative intra-articular myxoid liposarcoma with complex rearrangements involving EWSR1::DDIT3 detected using nanopore sequencing.
Makise N, Lin J, Kageyama H, Takeda N, Oikawa M, Sugiyama T, Kawana H, Araki A, Kinoshita H, Kamoda H, Hagiwara Y, Yoshida A, Yonemoto T, Kawazu M, Itami M. Makise N, et al. Among authors: yonemoto t. Pathol Int. 2024 Oct;74(10):604-610. doi: 10.1111/pin.13468. Epub 2024 Jul 29. Pathol Int. 2024. PMID: 39073367
Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinoma.
Yonemoto T, Ogasawara S, Kanogawa N, Miwa C, Fujiya M, Tsuchiya T, Sawada M, Akatsuka T, Izai R, Yumita S, Nakagawa M, Okubo T, Koroki K, Inoue M, Nakamura M, Kondo T, Nakamoto S, Itokawa N, Atsukawa M, Itobayashi E, Moriguchi M, Kato N. Yonemoto T, et al. Hepatol Res. 2025 May;55(5):718-729. doi: 10.1111/hepr.14160. Epub 2025 Jan 15. Hepatol Res. 2025. PMID: 40317555
Arrhythmias in centenarians.
Wakida Y, Okamoto Y, Iwa T, Yonemoto T, Kanemaki K, Shiomi T, Mizutani K, Kobayashi T. Wakida Y, et al. Among authors: yonemoto t. Pacing Clin Electrophysiol. 1994 Nov;17(11 Pt 2):2217-21. doi: 10.1111/j.1540-8159.1994.tb03829.x. Pacing Clin Electrophysiol. 1994. PMID: 7845846
Comprehensive molecular and clinicopathological profiling of desmoid tumours.
Kohsaka S, Hirata M, Ikegami M, Ueno T, Kojima S, Sakai T, Ito K, Naka N, Ogura K, Kawai A, Iwata S, Okuma T, Yonemoto T, Kobayashi H, Suehara Y, Hiraga H, Kawamoto T, Motoi T, Oda Y, Matsubara D, Matsuda K, Nishida Y, Mano H. Kohsaka S, et al. Among authors: yonemoto t. Eur J Cancer. 2021 Mar;145:109-120. doi: 10.1016/j.ejca.2020.12.001. Epub 2021 Jan 11. Eur J Cancer. 2021. PMID: 33444924 Free article.
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2.
Tozawa A, Kimura F, Takai Y, Nakajima T, Ushijima K, Kobayashi H, Satoh T, Harada M, Sugimoto K, Saji S, Shimizu C, Akiyama K, Bando H, Kuwahara A, Furui T, Okada H, Kawai K, Shinohara N, Nagao K, Kitajima M, Suenobu S, Soejima T, Miyachi M, Miyoshi Y, Yoneda A, Horie A, Ishida Y, Usui N, Kanda Y, Fujii N, Endo M, Nakayama R, Hoshi M, Yonemoto T, Kiyotani C, Okita N, Baba E, Muto M, Kikuchi I, Morishige KI, Tsugawa K, Nishiyama H, Hosoi H, Tanimoto M, Kawai A, Sugiyama K, Boku N, Yonemura M, Hayashi N, Aoki D, Suzuki N, Osuga Y. Tozawa A, et al. Among authors: yonemoto t. Int J Clin Oncol. 2022 Feb;27(2):281-300. doi: 10.1007/s10147-021-02076-7. Epub 2022 Jan 13. Int J Clin Oncol. 2022. PMID: 35022887 Free PMC article.
The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes.
Kanzaki H, Ishino T, Ogasawara S, Tsuchiya T, Fujiya M, Sawada M, Izai R, Akatsuka T, Miwa C, Yonemoto T, Yumita S, Nakagawa M, Kojima R, Koroki K, Inoue M, Kobayashi K, Kanogawa N, Nakamura M, Kondo T, Nakamoto S, Takayashiki T, Takano Y, Takata K, Lin J, Kawazu M, Ikeda JI, Ohtsuka M, Hoshida Y, Komuta M, Togashi Y. Kanzaki H, et al. Among authors: yonemoto t. JHEP Rep. 2025 Oct 1;7(12):101614. doi: 10.1016/j.jhepr.2025.101614. eCollection 2025 Dec. JHEP Rep. 2025. PMID: 41362708 Free PMC article.
183 results